Hastan D, Fokkens WJ, Bachert C, Newson RB, Bislimovska J, Bockelbrink A, et al. Chronic rhinosinusitis in Europe—an underestimated disease. A GA2LEN study. Allergy. 2011;66(9):1216–23.

Article  CAS  PubMed  Google Scholar 

Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg. 1995;113(1):104–9.

Article  CAS  PubMed  Google Scholar 

Sahlstrand-Johnson P, Ohlsson B, Von Buchwald C, Jannert M, Ahlner-Elmqvist M. A multi-centre study on quality of life and absenteeism in patients with CRS referred for endoscopic surgery. Rhinology. 2011;49(4):420–8.

Article  CAS  PubMed  Google Scholar 

Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the ‘top 10’ physical and mental health conditions affecting six large US employers in 1999. J Occup Environ Med. 2003;45(1):5–14.

Article  PubMed  Google Scholar 

Head K, Chong LY, Hopkins C, Philpott C, Burton MJ, Schilder AGM. Short-course oral steroids alone for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4(4):CD011991.

PubMed  Google Scholar 

Lange B, Holst R, Thilsing T, Baelum J, Kjeldsen A. Quality of life and associated factors in persons with chronic rhinosinusitis in the general population: a prospective questionnaire and clinical cross-sectional study. Clin Otolaryngol. 2013;38(6):474–80.

Article  CAS  PubMed  Google Scholar 

Baguley C, Brownlow A, Yeung K, Pratt E, Sacks R, Harvey R. The fate of chronic rhinosinusitis sufferers after maximal medical therapy. Int Forum Allergy Rhinol. 2014;4(7):525–32.

Article  PubMed  Google Scholar 

Young LC, Stow NW, Zhou L, Douglas RG. Efficacy of medical therapy in treatment of chronic rhinosinusitis. Allergy Rhinol (Providence). 2012;3(1):e8-12.

Article  PubMed  PubMed Central  Google Scholar 

Hopkins C, Slack R, Lund V, Brown P, Copley L, Browne J. Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Laryngoscope. 2009;119(12):2459–65.

Article  PubMed  Google Scholar 

Hopkins C, Browne JP, Slack R, Lund VJ, Topham J, Reeves BC, et al. Complications of surgery for nasal polyposis and chronic rhinosinusitis: the results of a national audit in England and Wales. Laryngoscope. 2006;116(8):1494–9.

Article  PubMed  Google Scholar 

Ramakrishnan VR, Kingdom TT, Nayak JV, Hwang PH, Orlandi RR. Nationwide incidence of major complications in endoscopic sinus surgery. Int Forum Allergy Rhinol. 2012;2(1):34–9.

Article  PubMed  Google Scholar 

Hopkins C, Conlon S, Chavda S, Hudson R, Rout R. Investigating the secondary care system burden of CRSwNP in sinus surgery patients with clinically relevant comorbidities using the HES database. Rhinology. 2022;60(4):252–60.

CAS  PubMed  Google Scholar 

Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl S29):1–464.

PubMed  Google Scholar 

Larsen K, Tos M. The estimated incidence of symptomatic nasal polyps. Acta Otolaryngol. 2002;122(2):179–82.

Article  PubMed  Google Scholar 

Johansson L, Akerlund A, Holmberg K, Melén I, Bende M. Prevalence of nasal polyps in adults: the Skövde population-based study. Ann Otol Rhinol Laryngol. 2003;112(7):625–9.

Article  PubMed  Google Scholar 

Takabayashi T, Schleimer RP. Formation of nasal polyps: the roles of innate type 2 inflammation and deposition of fibrin. J Allergy Clin Immunol. 2020;145(3):740–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klingler AI, Stevens WW, Tan BK, Peters AT, Poposki JA, Grammer LC, et al. Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps. J Allergy Clin Immunol. 2021;147(4):1306–17.

Article  CAS  PubMed  Google Scholar 

Staudacher AG, Peters AT, Kato A, Stevens WW. Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis. Ann Allergy Asthma Immunol. 2020;124(4):318–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394(10209):1638–50.

Article  CAS  PubMed  Google Scholar 

Han JK, Bachert C, Fokkens W, Desrosiers M, Wagenmann M, Lee SE, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021;9(10):1141–53.

Article  CAS  PubMed  Google Scholar 

Gevaert P, Omachi TA, Corren J, Mullol J, Han J, Lee SE, et al. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020;146(3):595–605.

Article  CAS  PubMed  Google Scholar 

Fokkens WJ, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019;74(12):2312–9.

Article  PubMed  Google Scholar 

Walter S, Ho J, Alvarado R, Smith G, Croucher DR, Liang S, et al. Mepolizumab decreases tissue eosinophils while increasing type-2 cytokines in eosinophilic chronic rhinosinusitis. Clin Exp Allergy. 2022;52:1403–13.

Article  CAS  PubMed  Google Scholar 

Bachert C, Han JK, Desrosiers MY, Gevaert P, Heffler E, Hopkins C, et al. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2022;149(4):1309-1317.e12.

Article  CAS  PubMed  Google Scholar 

AstraZeneca. A multicentre, randomised, double-blind, parallel-group, placebo-controlled phase 3 efficacy and safety study of benralizumab in patients with eosinophilic chronic rhinosinusitis with nasal polyps (ORCHID). clinicaltrials.gov; 2022 Nov [cited 2022 Nov 27]. Report No.: NCT04157335. https://clinicaltrials.gov/ct2/show/NCT04157335. Accessed 6 Apr 2023.

Weinstein SF, Katial RK, Bardin P, Korn S, McDonald M, Garin M, et al. Effects of reslizumab on asthma outcomes in a subgroup of eosinophilic asthma patients with self-reported chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2019;7(2):589-596.e3.

Article  PubMed  Google Scholar 

GlaxoSmithKline. A randomised, double-blind, parallel group phase III study to assess the efficacy and safety of 100 mg SC depemokimab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP)—ANCHOR-2 (depemokimAb iN CHrOnic Rhinosinusitis). clinicaltrials.gov; 2022 Dec [cited 2023 Jan 2]. Report No.: NCT05281523. https://clinicaltrials.gov/ct2/show/NCT05281523. Accessed 6 Apr 2023.

Singh D, Fuhr R, Bird NP, Mole S, Hardes K, Man YL, et al. A phase 1 study of the long-acting anti-IL-5 monoclonal antibody GSK3511294 in patients with asthma. Br J Clin Pharmacol. 2022;88(2):702–12.

Article  CAS  PubMed  Google Scholar 

Menzies-Gow A, Corren J, Israel E, Welte T, Ambrose CS, Cook B, et al. Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR. In: Airway pharmacology and treatment. European Respiratory Society; 2021 [cited 2022 Nov 29]. p. PA876. https://doi.org/10.1183/13993003.congress-2021.PA876.

AstraZeneca. Amulticentre, randomised, double-blind, parallel-group, placebo-controlled phase 3 efficacy and safety study of tezepelumab in participants with severe chronic rhinosinusitis with nasal polyposis (WAYPOINT). clinicaltrials.gov; 2022 Nov [cited 2022 Nov 28]. Report No.: NCT04851964. https://clinicaltrials.gov/ct2/show/NCT04851964. Accessed 6 Apr 2023.

Etokimab in adults with chronic rhinosinusitis with nasal polyps (CRSwNP) ClinicalTrials.gov. [cited 2023 Jan 4]. https://clinicaltrials.gov/ct2/show/NCT03614923. Accessed 6 Apr 2023.

Shen Y, Ke X, Hong S, Yang Y. Adverse events for biologics in patients with CRSwNP: a meta-analysis. Clin Transl Allergy. 2022;12(6): e12169.

Article  PubMed  PubMed Central  Google Scholar 

Chong LY, Piromchai P, Sharp S, Snidvongs K, Webster KE, Philpott C, et al. Biologics for chronic rhinosinusitis. Cochrane ENT Group, editor. Cochrane Database Syst Rev. 2021 [cited 2022 Nov 28];2021(10). https://doi.org/10.1002/14651858.CD013513.pub3.

Caminati M, Olivieri B, Dama A, Micheletto C, Paggiaro P, Pinter P, et al. Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management. Expert Rev Respir Med. 2022;16(7):713–21.

Article  CAS  PubMed  Google Scholar 

Briegel I, Felicio-Briegel A, Mertsch P, Kneidinger N, Haubner F, Milger K. Hypereosinophilia with systemic manifestations under dupilumab and possibility of dual benralizumab and dupilumab therapy in patients with asthma and CRSwNP. J Allergy Clin Immunol Pract. 2021;9(12):4477–9.

Article  CAS  PubMed  Google Scholar 

Agache I, Song Y, Alonso-Coello P, Vogel Y, Rocha C, Solà I, et al. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines. Allergy. 2021;76(8):2337–53.

Article  CAS  PubMed  Google Scholar 

Lourijsen ES, Reitsma S, Vleming M, Hannink G, Adriaensen GFJPM, Cornet ME, et al. Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial. Lancet Respir Med. 2022;10(4):337–46.

Article  PubMed  Google Scholar 

Thorwarth RM, Scott DW, Lal D, Marino MJ. Machine learning of biomarkers and clinical observation to predict eosinophilic chronic rhinosinusitis: a pilot study. Int Forum Allergy Rhinol. 2021;11(1):8–15.

Article  PubMed  Google Scholar 

Hopkins C, Han JK, Lund VJ, Bachert C, Fokkens WJ, Diamant Z, et al. Evaluating treatment response to mepolizumab in patients with severe CRSwNP. Rhinology. 2023;61:108–117.

Hopkins C, Lund V. Does time from previous surgery predict subsequent treatment failure in chronic rhinosinusitis with nasal polyps? Rhinology. 2021;59(3):277–83.

CAS  PubMed  Google Scholar 

Han JK, Bosso JV, Cho SH, Franzese C, Lam K, Lane AP, et al. Multidisciplinary consensus on a stepwise treatment algorithm for management of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2021;11(10):1407–16.

Article  PubMed  Google Scholar 

Snidvongs K, Kalish L, Sacks R, Sivasubramaniam R, Cope D, Harvey RJ. Sinus surgery and delivery method influence the effectiveness of topical corticosteroids for chronic rhinosinusitis: systematic review and meta-analysis. Am J Rhinol Allergy. 2013;27(3):221–33.

Article  PubMed  PubMed Central